Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-12-05

FDA Approved: OLOPATADINE HYDROCHLORIDE — Original Application (Apotex Corp.)

View source ↗

Summary

FDA approved the original ANDA for olopatadine hydrochloride ophthalmic solution from Apotex Corp., a generic antihistamine for allergic conjunctivitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OLOPATADINE HYDROCHLORIDE (olopatadine hydrochloride)

Snippet

ORIG AP for OLOPATADINE HYDROCHLORIDE (OLOPATADINE HYDROCHLORIDE)